15-72406686-T-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001080462.3(TMEM202):c.422T>A(p.Ile141Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000289 in 1,614,058 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001080462.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM202 | NM_001080462.3 | c.422T>A | p.Ile141Asn | missense_variant | 3/5 | ENST00000341689.4 | NP_001073931.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM202 | ENST00000341689.4 | c.422T>A | p.Ile141Asn | missense_variant | 3/5 | 5 | NM_001080462.3 | ENSP00000340212.3 | ||
TMEM202 | ENST00000649825.1 | c.89T>A | p.Ile30Asn | missense_variant | 3/5 | ENSP00000497819.1 | ||||
TMEM202 | ENST00000567679.1 | c.166T>A | p.Ser56Thr | missense_variant | 2/3 | 2 | ENSP00000456083.1 | |||
TMEM202 | ENST00000568167.5 | n.166T>A | non_coding_transcript_exon_variant | 2/4 | 2 | ENSP00000457632.1 |
Frequencies
GnomAD3 genomes AF: 0.000506 AC: 77AN: 152198Hom.: 2 Cov.: 32
GnomAD3 exomes AF: 0.000326 AC: 82AN: 251400Hom.: 0 AF XY: 0.000265 AC XY: 36AN XY: 135872
GnomAD4 exome AF: 0.000266 AC: 389AN: 1461860Hom.: 0 Cov.: 31 AF XY: 0.000248 AC XY: 180AN XY: 727236
GnomAD4 genome AF: 0.000506 AC: 77AN: 152198Hom.: 2 Cov.: 32 AF XY: 0.000686 AC XY: 51AN XY: 74350
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 27, 2021 | The c.422T>A (p.I141N) alteration is located in exon 3 (coding exon 3) of the TMEM202 gene. This alteration results from a T to A substitution at nucleotide position 422, causing the isoleucine (I) at amino acid position 141 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at